research use only
Cat.No.S8240
| Related Targets | CXCR Nrf2 Mitophagy LRRK2 ULK FKBP Heme Oxygenase cGAS LC3 Cell wall |
|---|---|
| Other Autophagy Inhibitors | Resveratrol (trans-Resveratrol) Spautin-1 PIK-III DC661 Lys05 Trihydrochloride Autophinib Spermidine EN6 Flubendazole QX77 |
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|---|---|---|---|---|---|
| PC12 | Function assay | 43 uM | Enhancement of autophagy in rat PC12 cells assessed as decrease in alpha-synuclein A53T mutant level at 43 uM by immunoblotting | 17486044 | ||
| COS7 | Function assay | 47 uM | 48 hrs | Inhibition of EGFP-tagged huntingtin aggregation expressed in african green monkey COS7 cells at 47 uM after 48 hrs by Western blot analysis | 17486044 | |
| COS7 | Function assay | 47 uM | 48 hrs | Inhibition of EGFP-tagged huntingtin expressed in african green monkey COS7 cells assessed as protection against protein-induced cell death at 47 uM after 48 hrs by Western blot analysis | 17486044 | |
| HeLa | Function assay | 47 uM | 24 hrs | Induction of autophagy in human HeLa cells harboring MAP1LC3 gene at 47 uM after 24 hrs by DAPI staining-based fluorescence microscopy | 17486044 | |
| HeLa | Function assay | 47 uM | 24 hrs | Increase in MAP1LC3 level in bafilomycin A1-treated human HeLa cells at 47 uM treated fro 24 hrs before bafilomycin A1 challenge by immunoblotting analysis | 17486044 | |
| PC12 | Function assay | 47 uM | 8 hrs | Enhancement of rapamycin-induced clearance of alpha-synuclein A53T mutant protein in rat PC12 cells at 47 uM after 8 hrs by immunoblotting | 17486044 | |
| COS7 | Function assay | 47 uM | 24 hrs | Inhibition of EGFP-tagged huntingtin aggregation expressed in african green monkey COS7 cells at 47 uM after 24 hrs by Western blot analysis in presence of 0.2 uM rapamycin | 17486044 | |
| PC12 | Function assay | 5 mg/ml | Enhancement of autophagy in rat PC12 cells assessed as decrease in alpha-synuclein A53T mutant level at 5 mg/ml by immunoblotting | 17486044 | ||
| PC12 | Function assay | 5 mg/ml | Enhancement of autophagy in rat PC12 cells assessed as decrease in alpha-synuclein A53T mutant level at 5 mg/ml by densitometry | 17486044 | ||
| PC12 | Function assay | 47 uM | Enhancement of autophagy in rat PC12 cells assessed as decrease in alpha-synuclein A53T mutant level at 47 uM by immunoblotting | 17486044 | ||
| Click to View More Cell Line Experimental Data | ||||||
|
In vitro |
DMSO
: 53 mg/mL
(200.66 mM)
Ethanol : 53 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 264.12 | Formula | C11H10BrN3 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 307538-42-7 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | C=CCNC1=NC=NC2=C1C=C(C=C2)Br | ||
| Targets/IC50/Ki |
Autophagy
|
|---|---|
| In vitro |
SMER28 is a positive regulator of autophagy in a mechanism independent from the mTOR pathway. It increases autophagosome synthesis and enhances the clearance of model autophagy substrates such as A53T a-synuclein and mutant huntingtin fragments. A marked decrease in Aβ/APP-CTF levels and enhancement for degradation of Aβ/APP-CTF via autophagy is also induced by this compound. APP-CTF and LC3-II are cocompartmentalized on this chemical treatment.
|
References |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.